SOURCE: Wall Street News Alert

Wall Street News Alert

February 14, 2008 08:43 ET

Wall Street News Alert: ELHI, Thursday's Hot Stock to Watch! February 14, 2008

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.

WESTON, FL--(Marketwire - February 14, 2008) - Wall Street News Alert's "stocks to watch" this morning are: Edgeline Holdings, Inc. (OTCBB: ELHI), Amgen Inc. (NASDAQ: AMGN), Celgene Corporation (NASDAQ: CELG) and Johnson & Johnson (NYSE: JNJ).

Edgeline Holdings, Inc. (OTCBB: ELHI), which recently announced a name change to Oncolin Therapeutics Inc., has issued more important news that should have investors attention this morning. Yesterday after the markets closed, the company issued a press release announcing that one of its research programs for which it has rights was awarded a peer reviewed National Institute Of Health Grant for $179,000 to support research on thermally targeted delivery of Doxorubicin.

This is great news for the company and its investors! There is a great need to develop drugs that target tumors to provide increased efficacy and reduced toxicity. According to the press release, preliminary results reported in this grant demonstrated that specific polypeptide doxorubicin conjugates showed increased cytoxicity and decreased toxicity when used in conjunction with hyperthermia. This research will be expanded to other drugs and animal testing to choose the best candidate to bring into clinical development.

Specific targeting of the proposed chemotherapeutic polypeptide carriers to solid tumors by local hyperthermia would increase specificity and efficacy of treatment and reduce the toxicity to normal tissues. This technology therefore represents a potential platform useful for a variety of chemotherapeutic agents.

"We are very happy that this program has received funding from such a prestigious organization as the NIH to help progress this potential platform technology," commented Dr. Donald Picker, COO of Edgeline Holdings, Inc.

Dr. Donald Picker first came to the attention of Wall Street News Alert on January 8, 2008, when it was announced in a company press release, that he had joined Intertech Bio. This was a great move for the company. Dr. Picker and his group were responsible for the development of Carboplatin, one of the world's leading cancer drugs currently in use with annual sales of over $500 million.

Wall Street News Alert is continuing to alert investors to monitor the progress of the company! Edgeline has recently announced it has obtained an exclusive option agreement with The University of Texas M.D. Anderson Cancer Center which provides the Company the right to negotiate a license for five technologies relating to the treatment of various cancers over a nine month period.

In addition, Oncolin has recently announced a Joint Development Agreement with Houston Pharmaceuticals to assist the Company in obtaining a license for certain patents, several of which are from the University of Mississippi and the University of Louisiana. Houston Pharmaceutical will continue collaborations with both universities and assist in securing grants on behalf of the company.

Prior to the latest press release, the stock closed Wednesday at Twenty Seven cents a share.

For an in-depth profile of Edgeline Holdings, visit

Amgen Inc. (NASDAQ: AMGN) up 1.1% on 8.9 million shares traded.

Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient.

Celgene Corporation (NASDAQ: CELG) up 0.9% on 3.4 million shares traded.

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation.

Johnson & Johnson (NYSE: JNJ) up 0.7% on 11.1 million shares traded.

Johnson & Johnson is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets.

Market Commentary:

"The Commerce Department reported Wednesday that retail sales rose by 0.3 percent last month. Sales had fallen by 0.4 percent in December as retailers suffered through their worst Christmas shopping season in five years," stated Sonja Rudd in Wall Street News Alert's daily commentary continued at:

Let Wall Street News Alert help advertise for your company using our effective awareness campaigns. If you're interested in telling your story, we can help. Contact us at or see our services at

WSNA's email alert service is free to those investors who sign up on the WSNA home page. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. The Wall Street News Alert home page has experienced over 100 million hits. To subscribe to this free service, visit the Wall Street News Alert home page at and select the "join now" button.

*** It has come to the attention of Wall Street News Alert (WSNA), that various persons or companies distribute faxes bearing similar names to Wall Street News Alert. Wall Street News Alert is not affiliated with faxes bearing names such as: Wall Street Stock Alert, Wall Street Investor Alert, Wall Street News Alert or any other fax using various combinations of the generic words Wall Street.***

Wall Street News Alert is a division of Wall Street Capital Funding LLC (WSCF). WSCF also maintains a contractual, working relationship with Stock Market Alerts LLC and its Wall Street Enews brand. WSCF is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. WSCF profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of WSCF and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and WSCF research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. WSCF disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. WSCF is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSCF profiled stocks.

This profile is not without bias, and is a paid release. WSCF has been compensated for dissemination of company information on behalf of one or more of the companies mentioned in this release. WSCF has been currently compensated Eighteen Thousand Dollars for coverage of Edgeline Holdings, Inc. (OTCBB: ELHI), by the company, for services provided including dissemination of company information in this release. WSCF was also previously compensated for services rendered in 2007; the previous compensation can be viewed by looking at a 2007 WSNA, ELHI press release. WSCF holds no shares of the stock. WSCF may receive additional compensation for extension of its services. Any additional compensation will be disclosed at such time that WSCF is aware of a client's desire to extend the original services. WSCF may have received shares of a company profiled in this release prior to the dissemination of the information in this release. WSCF may immediately sell some or any shares in a profiled company held by WSCF and may have previously sold shares in a profiled company held by WSCF. WSCF's services for a company may cause the company's stock price to increase, in which event WSCF would make a profit when it sells its stock in a company. In addition, WSCF's selling of a company's stock may have a negative effect on the market price of the stock.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WSCF undertakes no obligation to update such statements.

Contact Information